Retatrutide

Retatrutide (LY3437943) is the first single peptide to agonize three metabolic receptors at once: GLP-1, GIP and glucagon. Semaglutide activates one. Tirzepatide activates two.

Supplied as a lyophilized powder in a sealed glass vial at 5mg, 10mg or 15mg, requiring reconstitution with bacteriostatic water. Once-weekly dosing profile via a C18 fatty diacid moiety that extends half-life through albumin binding.

Reconstitute, then dose once weekly. A 10mg vial plus 2mL of bacteriostatic water gives 5mg/mL, so 0.1mL on a U-100 insulin syringe is 0.5mg. Halve the water for a 5mg vial, or use 3mL in a 15mg vial, to land on that same 5mg/mL. Aim the water down the glass wall, never at the powder, and swirl rather than shake.

Titration is the whole game. Start at the bottom of the range, hold each step for several weeks, and only move up once the current dose is comfortable. Trial protocols escalated over months, not weeks. The full photographed walkthrough is further down this page.

Nausea, vomiting, diarrhea and constipation are the most reported effects. They cluster during titration and in the first few days after a dose increase, then usually ease once you hold a dose steady. Resting heart rate runs a few beats higher.

Rare severe psychiatric events have been reported with incretin compounds, including retatrutide specifically. They are rare and causality is not established, but they are real and we are not going to bury them. If your mood shifts hard, stop. Full breakdown, including who should be most cautious, is in the safety section.

No. This is synthesized in the United States and every lot is verified by a US analytical lab before it is released.

That is worth asking about, because the default route in this market runs from an overseas synthesis house to a reseller who repackages bulk powder and never retests it. That is how retatrutide comes back as BPC-157, or assays at 62%. Your vial ships with HPLC and mass spectrometry results tied to the lot number crimped on the glass, so you are not taking anyone's word for the origin.

Independent testing on every lot is expensive and completely invisible on a product page, which is exactly why it is the first thing to get cut. The vendor charging half is not sourcing better, they are testing less or not at all.

One vendor's retatrutide came back as BPC-157. Another assayed at 62%. Neither was charging a premium for it. A cheap vial is only cheap if it contains what the label says.

Retatrutide is anecdotally one of the harder incretins to tolerate and people do stop. So start on the 5mg vial even though the bigger vials cost less per mg. Prove you tolerate it before you size up.

Once you know it works for you, sizing up to the 10mg or 15mg vial is the correct move. Lyophilized powder is stable in the freezer long term, and losing access to your source halfway through a protocol is the bigger risk in this market.

No trial has settled whether retatrutide is muscle sparing in humans, and we are not going to tell you it is.

What actually defends lean mass is roughly 1g of protein per pound of bodyweight and hard resistance training every week you run it. Chronic glucagon agonism can pull circulating amino acids down, so low protein plus this compound is the worst combination on the board.

Your vials, sealed and cold-packed, with a printed Certificate of Analysis matched to the exact lot number on the glass. Bacteriostatic water, insulin syringes and alcohol swabs are not included, so source those separately before your first dose.

Everything arrives in plain, unmarked packaging with tracking. Orders placed before midnight ship the next business day and typically land in 2 to 4 business days inside the US.

Lyophilized powder stores in the freezer at roughly −20°C, away from light, and is stable there long term. That is why buying the larger vial up front is the sensible move.

Once reconstituted it belongs in the refrigerator at 2°C to 8°C, on a shelf rather than in the door where temperature swings. Use reconstituted material within about four weeks and do not refreeze it.

Retatrutide is not a controlled substance. It is an investigational compound, not approved by the FDA for any indication, and Phase 3 trials are still running.

It is supplied here strictly for laboratory research use only and is not for human consumption. Regulatory treatment of research compounds varies by jurisdiction.